Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohammad

Showing results (321-330 of 367) with videos related to

Pageof 37
Sort By:
Heliyon|October 14, 2024
Genetic variability and diversity analysis for some agronomic traits of a sweet potato (<i>Ipomoea batatas</i> L.) collection: Insights for breeding superior genotypesZakaria Alam, Md Anwar Hossain Khan, Md Iqbal Hossain, et al.
Cancers|January 11, 2022
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell LymphomaHusain Yar Khan, Md Hafiz Uddin, Suresh Kumar Balasubramanian, et al.
Plos One|June 16, 2011
Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathwaysZhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, M S Shurafa, et al.
Plos One|July 14, 2017
Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cellsKirti S Prabhu, Kodappully S Siveen, Shilpa Kuttikrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, D S Eilender, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 15, 2011
Determinants of neurologic deterioration and stroke-free survival after spontaneous cervicocranial dissections: a multicenter studyAmeer E Hassan, Vikram Jadhav, Haralabos Zacharatos, et al.
East African Journal of Public Health|August 19, 2014
Institutional frameworks for management of epizoonotic emergencies in six countries in the Eastern Africa region: a situational analysisW Bazeyo, Roy W Mayega, I Nabukenya, et al.
Chemistry & Biodiversity|September 16, 2024
MRSA Inhibitory Activity of Some New Pyrazolo[1,5-a]pyrimidines Linked to Arene and/or Furan or Thiophene UnitsMohamed A A Elneairy, Emad G N Youssef, Sama A A Ebrahim, et al.
Molecular Cancer Therapeutics|September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoFardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Pageof 37

Showing results (321-330 of 367) with videos related to

Sort By:
Pageof 37
Heliyon|October 14, 2024
Genetic variability and diversity analysis for some agronomic traits of a sweet potato (<i>Ipomoea batatas</i> L.) collection: Insights for breeding superior genotypesZakaria Alam, Md Anwar Hossain Khan, Md Iqbal Hossain, et al.
Cancers|January 11, 2022
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell LymphomaHusain Yar Khan, Md Hafiz Uddin, Suresh Kumar Balasubramanian, et al.
Plos One|June 16, 2011
Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathwaysZhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, M S Shurafa, et al.
Plos One|July 14, 2017
Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cellsKirti S Prabhu, Kodappully S Siveen, Shilpa Kuttikrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemiaM L Varterasian, R M Mohammad, D S Eilender, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 15, 2011
Determinants of neurologic deterioration and stroke-free survival after spontaneous cervicocranial dissections: a multicenter studyAmeer E Hassan, Vikram Jadhav, Haralabos Zacharatos, et al.
East African Journal of Public Health|August 19, 2014
Institutional frameworks for management of epizoonotic emergencies in six countries in the Eastern Africa region: a situational analysisW Bazeyo, Roy W Mayega, I Nabukenya, et al.
Chemistry & Biodiversity|September 16, 2024
MRSA Inhibitory Activity of Some New Pyrazolo[1,5-a]pyrimidines Linked to Arene and/or Furan or Thiophene UnitsMohamed A A Elneairy, Emad G N Youssef, Sama A A Ebrahim, et al.
Molecular Cancer Therapeutics|September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoFardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Pageof 37